Fig. 3From: Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancera Skeletal-related event-free survival of cases administered MAB + EBRT and MAB + EBRT + PPB combination therapies. b Cytotoxic chemotherapy-free survival of cases administered MAB + EBRT and MAB + EBRT + PPB combination therapiesBack to article page